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Abstract
Our objective was to examine the cross-sectional associations between concentrations of vitamin 
A and beta-carotene, a major source of vitamin A, with concentrations of uric acid in a nationally 
representative sample of adults from the United States. We conducted a cross-sectional study 
using data from up to 10893 participants aged ≥20 years of National Health and Nutrition 
Examination Survey from 2001 to 2006. Concentrations of uric acid adjusted for numerous 
covariates increased from 305.8 μmol/L in the lowest quintile of vitamin A to 335.3 μmol/L in the 
highest quintile (p for linear trend <0.001). The prevalence ratio for hyperuricemia also increased 
progressively across quintiles of serum vitamin A reaching 1.82 (95% confidence interval [CI]: 
1.52, 2.16; p for linear trend <0.001) in the top quintile in the maximally adjusted model. Adjusted 
mean concentrations of uric acid decreased progressively from quintile 1 (333.8 μmol/L) through 
quintile 4 of concentrations of beta-carotene and were similar for quintiles 4 (313.5 μmol/L) and 5 
(313.8 μmol/L). Concentrations of beta-carotene were inversely associated with hyperuricemia 
(adjusted prevalence ratio comparing highest with lowest quintile = 0.61; 95% CI: 0.52, 0.72; p for 
linear trend <0.001). Concentrations of uric acid were significantly and positively associated with 
concentrations of vitamin A and inversely with concentrations of beta-carotene. These cross-
sectional findings require confirmation with experimental studies of vitamin A and beta-carotene 
supplementation.
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Gout is a common complication of hyperuricemia, an end product of the metabolism of 
purine nucleotides. In 1992, Mawson and Onor proposed a role for hypervitaminosis A in 
the etiology of gout and suggested that xanthine oxidase which converts xanthines to uric 
acid and retinol to retinoic acid could provide the underlying mechanism for their hypothesis 
[1]. However, little subsequent investigation has tested their hypothesis. Almost a decade 
earlier, the Food and Drug Administration had received reports of patients with acne who 
developed hyperuricemia and gout after using isotretinoin, a synthetic derivative of vitamin 
A [2]. A later report linked the use of acitretin, another derivative of vitamin A, to gouty 
tophi [3]. Furthermore, in at least one cross-sectional study, concentrations of uric acid were 
significantly and positively associated with concentrations of vitamin A and significantly 
and inversely associated with concentrations of beta-carotene [4]. More recently, an analysis 
of data from a large population-based survey showed that concentrations of vitamin A were 
directly and concentrations of beta-carotene were inversely associated with concentrations 
of uric acid [5].
Given the range of adverse health outcomes associated with high concentrations of uric acid 
[6–10], a thorough understanding of the impact of dietary and other factors on 
concentrations of uric acid may help in the development of approaches to minimize potential 
adverse effects among those who are at risk for complications attributable to hyperuricemia. 
Despite the recent publication of the results of a large cross-sectional study that examined 
the relationships between concentrations of vitamin A, beta-carotene and uric acid [5], a 
paucity of information on this topic still remains and additional investigations in this area 
are needed. Therefore, our objective was to examine the cross-sectional association between 
concentrations of vitamin A and uric acid in a large national sample of adults in the United 
States. Because beta-carotene is a provitamin A carotenoid that constitutes a valuable source 
of vitamin A, we also explored the association between circulating concentrations of this 
carotenoid and uric acid.
2. Methods and materials
2.1. Study population
The present analyses were conducted using data from three 2-year cycles (2001–2006) of the 
National Health and Nutrition Examination Survey (NHANES). A multistage, stratified 
sampling design was used to generate a sample of participants who were representative of 
the noninstitutionalized civilian US population. After an interview at home, participants 
were invited to complete additional questionnaires, undergo a set of tests, and provide blood 
and other biological specimens in the mobile examination center. Methodological details 
about the NHANES have been published [11]. The National Center for Health Statistics 
Research Ethics Review Board granted approval for the conduct of NHANES, and, 
participation in the study was contingent on signing an informed consent form. Because we 
analyzed public-use data from these surveys, which reside in the public domain, our study 
did not require human subjects review.
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The principal study variables comprised concentrations of uric acid, vitamin A, and beta-
carotene. In addition, we included the following covariates: age, gender, race or ethnicity 
(white, African American, Mexican American, and other), educational attainment (<high 
school, high school graduate or equivalent, >high school), cotinine concentration, leisure-
time physical activity, alcohol use, energy intake, hypertension, body mass index, estimated 
glomerular filtration rate, and concentrations of high-density lipoprotein cholesterol, non-
high-density lipoprotein cholesterol, and C-reactive protein. Participants were asked about 
engaging in moderate and vigorous physical activities and, for those who did, the time spent 
being physically active was calculated from their responses to the frequency and duration of 
the activities. The intakes of total energy intake and alcohol were obtained from information 
provided during a single 24-hour dietary recall. Body mass index (kg/m2) was calculated 
from measured weight and height. Up to four attempts were made to measure blood 
pressure. The average of the last two measurements of blood pressure for participants who 
had three measurements, the last measurement for participants with only two measurements, 
and the only measurement for participants who had one measurement were used. 
Hypertension was defined as a systolic blood pressure ≥140 mm Hg or diastolic blood 
pressure ≥90 mm Hg or the current use of antihypertensive medications by self-report.
2.3. Blood analyses
Serum concentrations of uric acid were measured on a Hitachi Model 917 multichannel 
analyzer (Roche Diagnostics, Indianapolis, IN) or a Beckman Synchron LX20 (Beckman 
Coulter, Inc., Brea, CA) after oxidation of uric acid by uricase to form allantoin and H2O2. 
Concentrations of uric acid were dichotomized as follows: 1) >416 μmol/L for men and 
>339 μmol/L for women, 2) >357 μmol/L regardless of gender, and 3) >416 μmol/ L 
regardless of gender [12–14]. Serum concentrations of vitamin A and serum concentrations 
of beta-carotene were measured by using high performance liquid chromatography (HPLC) 
with photodiode array detection on a Waters HPLC system (Waters Chromatography 
Division, Milford, MA) for cycles 1 and 3 and on a ThermoSeparation HPLC System 
(ThermoSeparation Products, CA) for cycle 2.
Concentrations of cotinine were determined by using isotope dilution - high performance 
liquid chromatography / atmospheric pressure chemical ionization tandem mass 
spectrometry. Serum creatinine was measured by using a Jaffé rate reaction on a Beckman 
Synchron CX3 clinical analyzer (Beckman Instruments, Inc., Brea, CA). Estimated 
glomerular filtration rate was calculated according to the Chronic Kidney Disease 
Epidemiology Collaboration (CKD-EPI) equation [15]. Concentrations of total cholesterol 
and high-density lipoprotein cholesterol (measured after precipitation of other lipoproteins 
with a polyanion-divalent cation mixture or measured directly) were measured 
enzymatically on Hitachi 704, 717, or 912 Analyzers (Roche Diagnostics (formerly 
Boehringer-Mannheim Diagnostics) (Hitachi Global Storage Technologies, San Jose, CA). 
Non-high-density lipoprotein cholesterol was calculated by subtracting the concentration of 
high-density lipoprotein cholesterol from that of total cholesterol. Concentrations of C-
reactive protein were measured by using latex-enhanced nephelometry on a Dade Behring 
Nephelometer II Analyzer System (BNII) (Dade Behring Diagnostics Inc., Somerville, NJ).
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The analyses were limited to participants who were aged ≥20 years and nonpregnant 
women. Chi-square tests and t-test were used to examine differences in percentages and 
means, respectively. Tests for trends of age-adjusted percentages or means were conducted 
by using orthogonal linear contrasts. Age-adjustment was performed using the direct method 
with the projected year 2000 U.S. population. Tests for differences in percentages or means 
after adjustment for study covariates were conducted by using linear regression analysis for 
continuous dependent variables and with log-linear regression analysis for dichotomous 
dependent variables. Tests for trends in percentages or means after adjustment for study 
covariates across quintiles of concentrations of vitamin A and beta-carotene were conducted 
by using linear regression analysis for continuous dependent variables and with log-linear 
regression analysis for dichotomous dependent variables using the median concentrations of 
vitamin A and beta-carotene of the quintiles. Least-square adjusted mean concentrations of 
uric acid were calculated by analysis of covariance. Prevalence ratios using dichotomized 
uric acid as the dependent variable were estimated by using log-linear analysis. Tests for 
trend for the prevalence ratios were conducted by using the median concentrations of 
vitamin A and beta-carotene of the quintiles. The statistical software SUDAAN (Research 
Triangle Institute, Research Triangle Park, NC) was used to generate the estimates.
3. Results
3.1. Analytical sample size
During the 6-year study period, 14542 participants attended the mobile examination center. 
After excluding pregnant women (n = 867), 12390 participants had data for both serum 
concentrations of vitamin A, beta-carotene, and uric acid. Additional exclusions for 
participants using medications to treat gout (n = 162) and participants who had missing data 
for covariates reduced the final sample size to 10893.
3.2. Characteristics of sample
The median age was 45 years, 49% were men, 73% were white, 10% were African 
American, 7% were Mexican American, 9% were of another race or ethnicity, and 57% had 
at least a high school diploma or its equivalent. The mean and median concentrations of uric 
acid were 320.5 and 315.2 μmol/L, respectively. The unadjusted prevalence of 
hyperuricemia was present in 20.6% (men: 23.2%, women: 18.1%) of participants using the 
gender-specific cut points, in 30.5% (men: 48.1%, women: 13.6%) of participants with a 
concentration of uric acid >357 μmol/L, and in 16.6% (men: 27.8%, women: 5.9%) of 
participants with a concentration of uric acid >416 μmol/L. The mean and median 
concentrations of vitamin A were 2.1 and 2.1 μmol/L, respectively, and of beta-carotene 
0.36 μmol /L and 0.23 μmol /L, respectively.
3.3. Study variables in relation to uric acid status
Compared to participants without hyperuricemia, those with hyperuricemia, defined using 
gender-specific cutpoints, were older (Table 1). In age-adjusted analyses, participants with 
hyperuricemia were more likely to be men and more likely to have hypertension, had a 
higher mean intake of alcohol, a higher mean body mass index, a lower mean concentration 
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of high-density lipoprotein cholesterol and higher mean concentration non-high-density 
lipoprotein cholesterol, a higher mean concentration of C-reactive protein, a lower mean 
estimated glomerular filtration rate, and a higher mean concentration of vitamin A. Most of 
these differences persisted in analyses that adjusted for covariates.
3.4. Study variables in relation to quintiles of concentrations of Vitamin A
Table 2 shows trends in age-adjusted means or percentages of covariates across quintiles of 
vitamin A. Except for concentrations of cotinine and high-density lipoprotein cholesterol, all 
other covariates displayed significant negative or positive trends. After adjustment for 
covariates, p-values lost statistical significance for several variables including physical 
activity, energy intake, body mass index, C-reactive protein, and beta-carotene.
After multiple adjustments, mean concentrations of uric acid increased steadily from 305.8 
μmol/L in the lowest quintile of vitamin A to 335.3 in the highest quintile (p for linear trend 
<0.001) (Fig.). The prevalence ratio for hyperuricemia also increased progressively across 
quintiles of serum vitamin A reaching 1.82 (95% confidence interval: 1.52, 2.16) in the top 
quintile in the maximally adjusted model (Table 3).
3.5. Study variables in relation to quintiles of concentrations of beta-carotene
Numerous significant linear trends were present for study covariates across quintiles of beta-
carotene concentrations (Table 4). Only the trends in the percentages of whites and mean 
estimated glomerular filtration rate were not significant.
After multiple adjustments, mean concentrations of uric acid decreased progressively from 
quintile 1 (333.8 μmol/L) through quintile 4 (313.5 μmol/L) of concentrations of beta-
carotene and were similar for quintiles 4 and 5 (Fig. 1). Concentrations of beta-carotene 
were inversely associated with hyperuricemia (Table 5).
4. Discussion
In this large cross-sectional study of a representative sample of U.S. adults, concentrations 
of uric acid and the likelihood of hyperuricemia were significantly and positively associated 
with vitamin A. Furthermore, the association demonstrated a dose–response relationship 
across quintiles of serum concentrations of vitamin A. In contrast, concentrations of uric 
acid were significantly and inversely associated with concentrations of beta-carotene.
Because of its role in various pathologies, identifying factors that contribute to elevations of 
concentrations of uric acid can yield new insights into therapeutic options to optimize 
concentrations of uric acid. Known lifestyle predictors of concentrations of uric acid include 
dietary factors (meat, seafood, dairy intake, fructose-rich foods and beverages), excess 
weight, and alcohol use [16]. Our results now suggest that vitamin A may also affect 
circulating concentrations of uric acid.
Good sources of dietary vitamin A are found in liver, carrots, broccoli, sweet potato, kale, 
spinach, pumpkins, and collard greens. Furthermore, a large percentage of adults take 
dietary supplements many of which contain vitamin A. During 2003–2006, 53% of 
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participants in NHANES reported using dietary supplements (54% of adults), and 33% 
reported using multivitamin/multimineral supplements [17]. For example, a leading 
multivitamin/multimineral supplement contains 3500 IU of vitamin A. Current 
recommended dietary allowances for vitamin A are 3000 IU (900 mcg) for men and 2310 IU 
(700 mcg) for women with additional allowances for pregnant and lactating women [18]. 
Although vitamin A deficiency is a major concern in many poor countries, intake of vitamin 
A may be high in developed countries due to the fortification of many foods and the use of 
supplements and may exceed the recommended daily allowance [19]. In the United States, 
however, 44% of the population had inadequate dietary intake of vitamin A during 2001–
2002 but the intake from supplementary sources was not specified [20]. If future clinical 
trials generate corroborating evidence about the effects of vitamin A intake on 
concentrations of uric acid, persons who suffer from gout or are prone to this condition may 
wish to consider moderating their intake of vitamin A [1].
Xanthine oxidase, which converts retinol to retinoic acid and xanthines to uric acid, provides 
a mechanistic explanation for why changes in concentrations of vitamin A may impact 
concentrations of uric acid.
The results from the present study are very consistent with those of a cross-sectional study 
that was recently published [5]. In an analysis of data from 14349 adults of a national survey 
conducted from 1988 to 1994 in the United States, concentrations of vitamin A were 
inversely associated with concentrations of uric acid. Compared to the lowest quintile of 
serum retinol, adjusted concentrations of uric acid were 42 μmol/L higher in the highest 
quintile of serum retinol. In comparison, the difference in adjusted concentrations of uric 
acid between the top and bottom quintile of serum retinol in the present study was about 29 
μmol/L. The differences in the estimates of the two studies that included two completely 
different representative samples of US adults may be due to sampling variation, to 
differences in adjustment factors, or to unobserved trends in factors that may influence 
concentrations of the study variables of interest.
Because of the cross-sectional design of the present study, the directionality of the 
association cannot be conclusively established. Based on a previous premise, we 
hypothesized that the arrow points from vitamin A to uric acid. Alternatively, uric acid 
concentrations may determine concentrations of vitamin A, or a common factor to both may 
provide the link between the two. Consequently, our findings need to be tested in 
experimental studies to establish whether the administration of vitamin A changes 
circulating concentrations of uric acid.
Beta-carotene is typically, but not exclusively, found in orange and yellow colored 
vegetables, and rich sources include sweet potatoes, carrots, kale, spinach, turnip greens, 
winter squash, collard greens, and some herbs such as cilantro and fresh thyme. When 
cleaved, beta-carotene yields vitamin A, and the inverse association between concentrations 
of beta-carotene and uric acid that we described may seem contrary to the direct association 
between concentrations of vitamin A and uric acid [21]. Other carotenoids with provitamin 
A activity include alpha-carotene and beta-cryptoxanthin but not lutein, zeaxanthin, and 
lycopene. Compared with retinol, however, beta-carotene in foods exhibits only a fraction of 
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the vitamin A activity [21]. It is conceivable that concentrations of beta-carotene represent 
markers for other constituents of fruits and vegetables that may be inversely related to 
concentrations of uric acid. Deserving of mention is that observational studies of beta-
carotene and adverse health outcomes have produced false signals in some instances as 
shown by the generally favorable associations between concentrations of beta-carotene and 
major causes of morbidity and mortality such as cancer and cardiovascular disease. 
Subsequent clinical trials failed to show a beneficial effect of the administration of beta-
carotene on cardiovascular disease and cancer [22,23].
Limited information about the associations between concentrations of beta-carotene and uric 
acid exists in the literature. At least three supplementation studies of beta-carotene have 
reported data about changes in concentrations of uric acid. Among 12 Dutch adults aged 18–
24 years, supplementation with microcrystalline beta-carotene suspension at 40 g/kg for 
three weeks did not significantly affect concentrations of uric acid (from 253 mmol/L to 244 
mmol/L) [24]. Concentrations of beta-carotene increased from 0.253 to 2.608 μmol/L. In a 
European multicenter trial, no significant change in concentration of uric acid among 35 
participants (mean age 34 years) who were supplemented with 15 mg/day of beta-carotene 
was reported after 12 weeks (343 μmol/L at week 0 and 360 μmol/L at week 12) [25]. 
Concentrations of beta-carotene increased from 0.39 to 1.66 μmol/L. However, another 
study that included 42 participants age 20–30 years who were supplemented with 5 mg, 10 
mg, 20 mg, and 40 mg of beta-carotene for five weeks did observe significant reductions in 
concentrations of uric acid [26]. Concentrations of beta-carotene increased from 0.36 to 0.83 
μmol/L, 0.24 to 1.43 μmol/L, 0.36 to 2.72 μmol/L, and 0.20 to 4.38 μmol/L in the four 
supplementation groups, respectively. These three supplementation studies provide 
inconsistent results about the possible effect of supplementation with beta-carotene on 
concentrations of uric acid, and only one of the studies is consistent with the findings of our 
analyses. Consequently, additional supplementation studies with larger sample sizes should 
prove useful shedding light on the nature of the relationship between beta-carotene and uric 
acid. Concentrations of beta-carotene achieved after supplementation were higher than the 
median concentration of 0.734 μmol/L in the highest quartile in our study.
A limited number of observational studies provide supportive evidence for the associations 
between concentrations of vitamin A, beta-carotene, and uric acid that we noted. In a study 
of 415 Australian adults aged 60–64 years, concentrations of uric acid were positively 
correlated with concentrations of vitamin A (r = 0.216, P < .001) and negatively correlated 
with concentrations of beta-carotene (r = −0.24, P < .001) [4]. Recently, concentrations of 
beta-carotene were found to be inversely associated with concentrations of uric acid among 
14,349 participants aged ≥20 years in the Third National Health and Nutrition Examination 
Survey conducted from 1988 to 1994 [5]. Thus, the results of that completely separate 
population-based study based on data from a survey that was conducted more than a decade 
earlier were very consistent with the results of the present study. Nevertheless, additional 
research is needed to shed light on the relationships between beta-carotene and 
concentrations of uric acid and the mechanisms underlying such a relationship, if a 
relationship is confirmed.
Ford and Choi Page 7













The principal limitation of our study is its cross-sectional design. In addition, study variables 
may have been imperfectly measured and we may not have included all relevant 
confounders. Consequently, the results are subject to the possibility of residual confounding.
In conclusion, concentrations of vitamin A were positively and concentrations of beta-
carotene were inversely associated with concentrations of uric acid. These results, if 
confirmed by experimental studies, possibly point to approaches to preventing elevated 
concentrations of uric acid.
Abbreviation
NHANES National Health and Nutrition Examination Survey
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Adjusted mean concentrations (95 % confidence interval) of serum uric acid among adults 
aged ≥ 20 years, by quintiles of concentrations of serum, vitamin A (panel A) and beta-
carotene (panel B). National Health and Nutrition Examination Survey. Results are adjusted 
for age, gender, race or ethnicity, education, cotinine concentraion, leisure-time physical 
activity, alcohol intake, energy intake, hypertension, body mass index, high-density 
lipoprotein cholesterol, non-high-density lipoprotein cholesterol, estimated glomerular 
filtration rate, C-reactive protein, and beta-carotene (panel A) or serum vitamin A (panel B).
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Table 1
Selected age-adjusted baseline characteristics among U.S. adults aged ≥20 years, by hyperuricemia status, 
National Health and Nutrition Examination Survey 2001–2006
Characteristics Hyperuricemia a No hyperuricemia P P b
Mean or % (95% CI) Mean or % (95% CI)
N, unweighted 2346 8547 – –
Age (years) 49.9 (48.8, 51) 45.1 (44.4, 45.7) < .001 < .001
Men, % 58.0 (55.7, 60.2) 47.3 (46.3, 48.3) < .001 .220
Whites, % 73.4 (69.1, 77.2) 73.7 (70.5, 76.6) .756 < .001
>High school, % 54.3 (50.9, 57.7) 57.0 (54.8, 59.1) .141 .174
Cotinine (ng/ml) 63.2 (55.1, 71.3) 65.7 (60.4, 7.0) .514 .148
Alcohol intake (g/d) 17.8 (15.2, 20.4) 11.5 (10.4, 12.6) < .001 < .001
Leisure-time physical activity (MET-h/month) 84.2 (72.3, 96.1) 77.7 (72.5, 83.0) .285 .050
Energy intake (kcals/d) 2255 (2202, 2308) 2245 (2219, 2272) .736 < .001
Hypertension, % 43.6 (40.8, 46.3) 26.3 (25.2, 27.4) < .001 < .001
Body mass index (kg/m2) 31.2 (30.7, 31.7) 27.3 (27.1, 27.5) < .001 < .001
High-density lipoprotein cholesterol (mmol/L) 1.26 (1.24, 1.28) 1.41 (1.4, 1.42) < .001 < .001
Non-high-density lipoprotein cholesterol (mmol/L) 4.12 (4.06, 4.18) 3.74 (3.71, 3.77) < .001 .005
C-reactive protein (mg/L) 5.2 (4.7, 5.6) 3.8 (3.6, 3.9) < .001 .004
Estimated glomerular filtration rate (mL/min per 1.73 m2) 87.9 (87.0, 88.9) 95.1 (94.4, 95.8) < .001 < .001
Serum vitamin A (μmol/L) 2.3 (2.3, 2.3) 2.1 (2.1, 2.1) < .001 < .001
Beta-carotene (μmol/L) 0.3 (0.3, 0.3) 0.4 (0.4, 0.4) < .001 < .001
Uric acid (μmol/L) 431 (429, 434) 292 (291, 294) < .001 < .001
a
Hyperuricemia is defined as >416 μmol/L in men and >339 μmol/L in women.
b
P-values for differences adjusted for all other covariates in table.
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